Oncolytic virotherapy is an effective cancer treatment using a special virus, which is capable of finding and destroying cells of a malignant tumour in human body. Medicinal product is intramuscularly injected in a body. Virotherapy usually takes place on out-patients' basis pursuant to tailor-made treatment protocol and in accordance with the application guidelines. Average treatment period is 3 years during which a regular monitoring of analyses and patient observation takes place.
Cancer virotherapy is a treatment method that is gentle to a body and has minimum side effects. Most common side effect is slightly increased body temperature (up to 37.50C) lasting one to three days.
Patient contacts IVC Information Centre or a doctor specialising in virotherapy.
Patient makes the necessary analyses and sends the results to the doctor.
After reading patient's medical history and analyses, the doctor provides a recommendation regarding a possibility to use virotherapy.
If the virotherapy is possible, an individual treatment schedule is elaborated, matching the patient's immunity condition, type of cancer, localisation and tumour stage.
The virotherapy course of treatment is commenced – a patient receives first medication injections.
Frequency of medication injections usually decreases during the course of treatment.
Regular monitoring of analyses and patient observation take place.
Treatment schedule can be corrected depending on the results of analyses.